Epilepsy, Temporal Lobe: Clinical Trials

4 trials for Epilepsy, Temporal Lobe, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 2 terminated. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 2, Terminated 2
Phase 11Recruiting 1

Follow Epilepsy, Temporal Lobe: new trials by email Literature Review of Epilepsy, Temporal Lobe trials Research Report on Epilepsy, Temporal Lobe

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy
Ferumoxytol - Epilepsy, Temporal Lobe
Phase 2RecruitingUniversity of Alberta502025-05-012026-05-08
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
NRTX-1001 - Epilepsy, Temporal Lobe
Phase 1 / Phase 2RecruitingNeurona Therapeutics102024-11-142026-01-07
Buspirone Therapy for Localized Epilepsy
Buspirone, Placebo - Anxiety Disorder, Seizures
Phase 2TerminatedNational Institute of Neurological Disorders and Stroke (NINDS)92011-11-222021-10-05
PRX-00023 Therapy in Localization-Related Epilepsy
PRX-00023, Placebo - Epilepsy, Epilepsy, Temporal Lobe
Phase 2TerminatedNational Institute of Neurological Disorders and Stroke (NINDS)122011-01-072018-12-07

Narrower conditions

Epilepsies, Partial (2)  ·  Epilepsy (2)  ·  Anxiety Disorders (1)  ·  Depression (1)  ·  Seizures (1)

Broader conditions

Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Epileptic Syndromes (4)  ·  Nervous System Diseases (4)  ·  Epilepsies, Partial (2)  ·  Epilepsy (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Mental Disorders (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Buspirone (1)  ·  Ferrosoferric Oxide (1)  ·  naluzotan (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (2)  ·  Neurona Therapeutics (1)  ·  University of Alberta (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

William H Theodore, M.D. (2)  ·  Donald Gross, MD (1)  ·  Eduardo Dunayevich, MD (1)